Medicamen Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Medicamen Biotech has a total shareholder equity of ₹2.0B and total debt of ₹290.2M, which brings its debt-to-equity ratio to 14.5%. Its total assets and total liabilities are ₹3.0B and ₹975.1M respectively. Medicamen Biotech's EBIT is ₹161.6M making its interest coverage ratio 6.1. It has cash and short-term investments of ₹134.3M.
Key information
14.5%
Debt to equity ratio
₹290.20m
Debt
Interest coverage ratio | 6.1x |
Cash | ₹134.29m |
Equity | ₹2.00b |
Total liabilities | ₹975.08m |
Total assets | ₹2.97b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 531146's short term assets (₹1.8B) exceed its short term liabilities (₹940.7M).
Long Term Liabilities: 531146's short term assets (₹1.8B) exceed its long term liabilities (₹34.4M).
Debt to Equity History and Analysis
Debt Level: 531146's net debt to equity ratio (7.8%) is considered satisfactory.
Reducing Debt: 531146's debt to equity ratio has increased from 3.9% to 14.5% over the past 5 years.
Debt Coverage: 531146's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 531146's interest payments on its debt are well covered by EBIT (6.1x coverage).